Karra, Laila http://orcid.org/0000-0001-5503-2809
Romero-Moya, Damia
Ksionda, Olga
Krush, Milana
Gu, Zhaohui
Mues, Marsilius
Depeille, Philippe
Mullighan, Charles http://orcid.org/0000-0002-1871-1850
Roose, Jeroen P. http://orcid.org/0000-0003-4746-2811
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01 - CA187318, CA021765, R35 CA197695)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01 - HL120724)
Alex’s Lemonade Foundation Innovator Award
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
St. Baldrick’s Foundation Robert J. Arceci Innovation award
Article History
Received: 14 May 2020
Accepted: 10 September 2020
First Online: 28 September 2020
Compliance with ethical standards
:
: Jeroen Roose is a co-founder and scientific advisor of Seal Biosciences, Inc. and on the scientific advisory committee for the Mark Foundation for Cancer Research. C.G.M. receives research funding from Loxo Oncology, Abbvie, and Pfizer, and speaking fees from Amgen.